ClinicalTrials.Veeva

Menu

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

T

Toulouse University Hospital

Status

Unknown

Conditions

Ventricular Tachycardia

Treatments

Procedure: ventricular tachycardia ablation

Study type

Observational

Funder types

Other

Identifiers

NCT03453645
2017-A00582-51 (Other Identifier)
RC31/17/0066

Details and patient eligibility

About

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias.

Full description

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias.

Rhythmic risk assessment criterions have never been studied in relation with ventricular tachycardia ablation. The purpose of this study is to explore the modifications of these criterions after ventricular tachycardia ablation.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing ventricular tachycardia,
  • patients with ischemic cardiomyopathy according to European Society of Cardiology Guidelines,
  • patients with implanted cardiac defibrillator.

Exclusion criteria

  • Contra-indication to stress test,
  • permanent atrial fibrillation,
  • permanent ventricular pacing,
  • left bundle block.

Trial contacts and locations

1

Loading...

Central trial contact

Philippe MAURY, MD; Isabelle OLIVIER, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems